AI Article Synopsis

  • Differences/disorders of sex development (DSDs) in individuals with a 46, XY karyotype are congenital conditions that lead to issues like underdeveloped male gonads or abnormal external genitalia, with about 50% of patients lacking a molecular diagnosis.
  • This paper reviews common and rare genes associated with 46, XY DSDs, explores the prevalence of these genes worldwide, and looks at factors influencing detection results across different cohorts.
  • Next-generation sequencing (NGS), particularly whole-exome sequencing (WES), is highlighted as an effective tool for diagnosis, with issues in detection linked to varying enrollment criteria and sequencing methods.

Article Abstract

Differences/disorders of sex development (DSDs) in individuals with a 46, XY karyotype are a group of congenital disorders that manifest as male gonadal hypoplasia or abnormalities of the external genitalia. Approximately 50% of patients with 46, XY DSDs cannot obtain a molecular diagnosis. The aims of this paper were to review the most common causative genes and rare genes in patients with 46, XY DSDs, analyze global molecular diagnostic cohorts for the prevalence and geographic distribution of causative genes, and identify the factors affecting cohort detection results. Although the spectrum of genetic variants varies across regions and the severity of the clinical phenotype varies across patients, next-generation sequencing (NGS), the most commonly used detection method, can still reveal genetic variants and aid in diagnosis. A comparison of the detection rates of various sequencing modalities revealed that whole-exome sequencing (WES) facilitates a greater rate of molecular diagnosis of the disease than panel sequencing. Whole-genome sequencing (WGS), third-generation sequencing, and algorithm advancements will contribute to the improvement of detection efficiency. The most commonly mutated genes associated with androgen synthesis and action are , , and , and the most commonly mutated genes involved in gonadal formation are and Detection results are affected by differences in enrollment criteria and sequencing technologies.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11194351PMC
http://dx.doi.org/10.3389/fgene.2024.1387598DOI Listing

Publication Analysis

Top Keywords

differences/disorders sex
8
sex development
8
patients dsds
8
molecular diagnosis
8
causative genes
8
genetic variants
8
commonly mutated
8
mutated genes
8
sequencing
7
genes
5

Similar Publications

In-depth exploration of differences of sex development: 5-year experience in a tertiary center.

Endocr Connect

October 2024

Laboratory of Biotechnology, Environment, Food, and Health, Faculty of Sciences Dhar El Mahraz, Sidi Mohammed Ben Abdellah University, Fez, Morocco.

Background: Differences/disorders of sex development (DSD) encompass a wide range of conditions. Their clinical spectrum and etiological diagnosis have not been reported in Moroccan patients.

Aims: The study aims to highlight the clinical spectrum, etiological diagnosis, and management of patients with DSD.

View Article and Find Full Text PDF

 : Differences/disorders of sex development can be caused by disruptions to the molecular and cellular mechanisms that control development and sex determination of the reproductive organs with 1:100 live births affected. Multiple genes are associated with 46, XY differences/disorders of sex development that can cause varying clinical phenotypes. An accurate genetic diagnosis is essential to guide clinical care for individuals with 46, XY differences/disorders of sex development and can contribute to family planning.

View Article and Find Full Text PDF
Article Synopsis
  • Differences/disorders of sex development (DSDs) in individuals with a 46, XY karyotype are congenital conditions that lead to issues like underdeveloped male gonads or abnormal external genitalia, with about 50% of patients lacking a molecular diagnosis.
  • This paper reviews common and rare genes associated with 46, XY DSDs, explores the prevalence of these genes worldwide, and looks at factors influencing detection results across different cohorts.
  • Next-generation sequencing (NGS), particularly whole-exome sequencing (WES), is highlighted as an effective tool for diagnosis, with issues in detection linked to varying enrollment criteria and sequencing methods.
View Article and Find Full Text PDF

Long-term outcomes in non-CAH 46,XX DSD.

Front Endocrinol (Lausanne)

May 2024

AP-HP, Pitié-Salpêtrière Hospital, IE3M, and Centre de Référence des Maladies Endocriniennes Rares de la Croissance, and Centre de Référence des Pathologies Gynécologiques Rares, Department of Endocrinology and Reproductive Medicine, Sorbonne Université, Paris, France.

Differences/disorders of sex development (DSD) comprise a large group of rare congenital conditions. 46,XX DSD, excluding congenital adrenal hyperplasia (CAH), represent only a small number of these diseases. Due to the rarity of non-CAH 46,XX DSD, data on this sex chromosomal aberration were confined to case reports or case series with small numbers of patients.

View Article and Find Full Text PDF

Unlabelled: Differences/Disorders of sex development (DSDs) are conditions in which the development of chromosomal, gonadal, and anatomical sexes is atypical. DSDs are relatively rare, but their incidence is becoming alarmingly common in sub-Saharan Africa (SSA). Their etiologies and mechanisms are poorly understood.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!